Management mitigating risk by adding clinical sites in two countries and making protocol changes Timing for top-line results remains unchanged, still expected in Q4 2022 VICTORIA, BC – Eupraxia Pharmaceuticals… Read More
Silicon Valley Bank is very proud to announce that they were named to Newsweek and Statista Charts‘ annual list of America’s Most Responsible Companies. “Corporations aren’t just impersonal machines for… Read More
VANCOUVER, BC – Jill Earthy has been appointed the first Chief Executive Officer of InBC Investment Corp. (InBC) a newly created Crown corporation responsible for a $500-million strategic investment fund that… Read More
VANCOUVER, BC – AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, announced today the appointment of Neil Aubuchon as Chief Commercial Officer (CCO). Mr. Aubuchon… Read More
VANCOUVER, BC – Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that Janssen Biotech, Inc. (“Janssen”) dosed the first patient with JNJ-78306358, a bispecific antibody… Read More
